Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2446 AL 2460

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study

Molinuevo JL, Gispert JD, Dubois B, Heneka MT, Lleo A, Engelborghs S, Pujol J, de Souza LC, Alcolea D, Jessen F, Sarazin M, Lamari F, Balasa M, Antonell A, Rami L.

J Alzheimers Dis. 2013;36(1):67-77. doi: 10.3233/JAD-130203.

[Inflammatory markers in Alzheimer's disease and vascular dementia]

Androsova LV, Mikhaĭlova NM, Zozulia SA, Dupin AM, Rassadina GA, Lavrent'eva NV, Kliushnik TP.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(2):49-53.

Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals

Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ.

J Neurosci. 2013 Mar 27;33(13):5553-63. doi: 10.1523/JNEUROSCI.4409-12.2013.

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

Landau SM, Lu M, Joshi AD, Pontecorvo M, Mintun MA, Trojanowski JQ, Shaw LM, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2013 Dec;74(6):826-36. doi: 10.1002/ana.23908.

Machine learning and social network analysis applied to Alzheimer's disease biomarkers

Di Deco J, González AM, Díaz J, Mato V, García-Frank D, Álvarez-Linera J, Frank A, Hernández-Tamames JA.

Curr Top Med Chem. 2013;13(5):652-62. doi: 10.2174/1568026611313050008.

Effect of cognitive reserve markers on Alzheimer pathologic progression

Lo RY, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):343-50. doi: 10.1097/WAD.0b013e3182900b2b.

Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria

Sperling R, Johnson K.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):325-38. doi: 10.1212/01.CON.0000429181.60095.99.

BIN1 gene rs744373 polymorphism contributes to Alzheimer's disease in East Asian population

Liu G, Zhang S, Cai Z, Li Y, Cui L, Ma G, Jiang Y, Zhang L, Feng R, Liao M, Chen Z, Zhao B, Li K.

Neurosci Lett. 2013 Jun 7;544:47-51. doi: 10.1016/j.neulet.2013.02.075. Epub 2013 Apr 6.

Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process

Stefani A, Olivola E, Stampanoni Bassi M, Pisani V, Imbriani P, Pisani A, Pierantozzi M.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):538-46. doi: 10.2174/1871527311312040016.

Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer's disease

Tiedt HO, Lueschow A, Winter P, Müller U.

Neurosci Lett. 2013 Jun 7;544:115-8. doi: 10.1016/j.neulet.2013.03.056. Epub 2013 Apr 10.

Smell identification function as a severity and progression marker in Alzheimer's disease

Velayudhan L, Pritchard M, Powell JF, Proitsi P, Lovestone S.

Int Psychogeriatr. 2013 Jul;25(7):1157-66. doi: 10.1017/S1041610213000446. Epub 2013 Apr 19.

Comparison between clinical diagnosis and CSF biomarkers of Alzheimer disease in elderly patients with late onset psychosis: Helsinki Old Age Psychosis Study (HOPS)

Seppälä TT, Louhija UM, Appelberg B, Herukka SK, Juva K.

Am J Geriatr Psychiatry. 2014 Sep;22(9):908-16. doi: 10.1016/j.jagp.2012.08.020. Epub 2013 Apr 15.

[New risk genes for Alzheimer's disease--biomarkers predicting the disease?]

Hiltunen M, Haapasalo A, Soininen H.

Duodecim. 2013;129(6):583-8.

Alzheimer's disease biomarkers: correspondence between human studies and animal models

Sabbagh JJ, Kinney JW, Cummings JL.

Neurobiol Dis. 2013 Aug;56:116-30. doi: 10.1016/j.nbd.2013.04.010. Epub 2013 Apr 28.

Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease

Schmitt A, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):271-2. doi: 10.1007/s00406-013-0409-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias